ELAB
PMGC Holdings Inc.
Key Financials
Operating Income
$-4414143
N/A
Revenue
$590084
↓ 65.5%
Net Income
$-7747813
↓ 24.0%
Total Assets
$12.9M
↑ 43.1%
Gross Profit
$185314
↓ 83.7%
EPS (Diluted)
$-0.40
↓ 111.6%
Total Liabilities
$5.0M
↑ 115.6%
Cash & Equivalents
$4.0M
↑ 19.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| PRE 14C | 4/17/2026 | View on SEC |
| 8-K | 4/17/2026 | View on SEC |
| 8-K | 4/9/2026 | View on SEC |
| 8-K | 4/8/2026 | View on SEC |
| 8-K | 4/6/2026 | View on SEC |
| 8-K | 4/2/2026 | View on SEC |
| 424B5 | 4/1/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELAB |
| Company Name | PMGC Holdings Inc. |
| CIK | 1840563 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888-445-4886 |